Log In
Print
BCIQ
Print
Print this Print this
 

MKC1106-PP

  Manage Alerts
Collapse Summary General Information
Company MannKind Corp.
DescriptionPlasmid DNA encoding preferentially expressed antigen of melanoma (PRAME) and prostate-specific membrane antigen (PSMA) plus synthetic peptide analogs of PRAME and PSMA
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid malignancies
Regulatory Designation

Partner

Colby Pharmaceutical Co.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today